Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries

References

• Bjoro K, Friman S, Hockerstedt K, Kirkegaard P, Keiding S, Schrumpf E, et al. Liver transplantation in the Nordic countries, 1982–1998: changes of indications and improving results. Scand J Gastroenterol 1999;34:714–22.
   PubMed Web of Science ®Google Scholar
• Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992;16:1290–9.
   PubMed Web of Science ®Google Scholar
• Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995;117:146–55.
   PubMedGoogle Scholar
• Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22: 451–7.
   Google Scholar
• Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999;30:1121–7.
   PubMed Web of Science ®Google Scholar
• Organ Procurement and Transplantation Network 2002. www. OPTN.org.2003.
   Google Scholar
• Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987;22:655–64.
   PubMed Web of Science ®Google Scholar
• Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321–7.
   PubMed Web of Science ®Google Scholar
• Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002;37:1205–11.
   PubMed Web of Science ®Google Scholar
• Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38:610–5.
   PubMed Web of Science ®Google Scholar
• Leidenius M, Hockerstedt K, Broome U, Ericzon BG, Friman S, Olausson M, et al. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. J Hepatol 2001;34:792–8.
   PubMed Web of Science ®Google Scholar
• Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, Jr, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21–5.
   PubMed Web of Science ®Google Scholar
• Ahrendt SA, Pitt HA, Kalloo AN, Venbrux AC, Klein AS, Herlong HF, et al. Primary sclerosing cholangitis: resect, dilate, or transplant? Ann Surg 1998;227:412–23.
   PubMed Web of Science ®Google Scholar
• Brandsaeter B, Broome U, Isoniemi H, Friman S, Hansen B, Schrumpf E, et al. Liver transplantation for primary sclerosing cholangitis: focus on the outcome following acceptance on the waiting list; a prospective study from the Nordic countries. Liver Transpl 2003;9:961–9.
   PubMed Web of Science ®Google Scholar
• Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. 2003 Unpublished work.
   Google Scholar
• Cattan P, Berney T, Conti F, Calmus Y, Homberg JC, Houssin D, et al. Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes. Transpl Int 2002;15:34–8.
   PubMedGoogle Scholar
• Ghobrial RM, Gornbein J, Steadman R, Danino N, Markmann JF, Holt C, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002;236:315–22.
   PubMedGoogle Scholar
• Garcia CE, Garcia RF, Mayer AD, Neuberger J. Liver transplantation in patients over sixty years of age. Transplantation 2001;72:679–84.
   PubMedGoogle Scholar
• Neuberger J, Gunson B, Komolmit P, Davies MH, Christensen E. Pretransplant prediction of prognosis after liver transplantation in primary sclerosing cholangitis using a Cox regression model. Hepatology 1999;29:1375–9.
   Google Scholar
• Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91–6.
   PubMed Web of Science ®Google Scholar
• Busuttil RW, Shaked A, Millis JM, Jurim O, Colquhoun SD, Shackleton CR, et al. One thousand liver transplants. The lessons learned. Ann Surg 1994;219:490–7.
   PubMed Web of Science ®Google Scholar
• Grande L, Rull A, Rimola A, Manyalic M, Cabrer C, Garcia-Valdecasas JC, et al. Impact of donor gender on graft survival after liver transplantation. Transplant Proc 1997;29:3373–4.
   Google Scholar
• Marino IR, Doria C, Doyle HR, Gayowski TJ. Matching donors and recipients. Liver Transpl Surg 1998;4(5 Suppl 1):9.
   Google Scholar
• Busquets J, Xiol X, Figueras J, Jaurrieta E, Torras J, Ramos E, et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001;71:1765–71.
   PubMedGoogle Scholar
• Marino IR, Doyle Hr, Aldrighetti L, Doria C, McMichael J, Gayowski T, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995;22:1754–62.
   Google Scholar
• Krom RA, Wiesner RH, Rettke SR, Ludwig J, Southorn PA, Hermans PE, et al. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 1989;64:84–94.
   PubMed Web of Science ®Google Scholar
• Wiesner RH. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Practice Res Clin Gastroenterol 2001;15:667–80.
   PubMed Web of Science ®Google Scholar